266 related articles for article (PubMed ID: 33173335)
1. Development and Validation of Nomograms for Predicting Cancer-Specific Survival in Elderly Patients with Intrahepatic Cholangiocarcinoma After Liver Resection: A Competing Risk Analysis.
Wang T; Zhang J; Wang W; Yang X; Kong J; Shen S; Wang W
Cancer Manag Res; 2020; 12():11015-11029. PubMed ID: 33173335
[TBL] [Abstract][Full Text] [Related]
2. A competing risk nomogram predicting cause-specific mortality in patients with lung adenosquamous carcinoma.
Wu X; Yu W; Petersen RH; Sheng H; Wang Y; Lv W; Hu J
BMC Cancer; 2020 May; 20(1):429. PubMed ID: 32416716
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of a Nomogram for Differentiating Combined Hepatocellular Cholangiocarcinoma From Intrahepatic Cholangiocarcinoma.
Wang T; Wang W; Zhang J; Yang X; Shen S; Wang W
Front Oncol; 2020; 10():598433. PubMed ID: 33363028
[TBL] [Abstract][Full Text] [Related]
4. Incidence Trend and Competing Risk Analysis of Patients With Intrahepatic Cholangiocarcinoma: A Population-Based Study.
Xing H; Tan B; Yang C; Zhang M
Front Med (Lausanne); 2022; 9():846276. PubMed ID: 35433765
[TBL] [Abstract][Full Text] [Related]
5. Predicting cancer-specific mortality in T1/2 hepatocellular carcinoma after radiofrequency ablation by competing risk nomogram: A population-based analysis.
He Q; Xiong Y; Xia P; Yang X; Yu Y; Chen Z
Clin Res Hepatol Gastroenterol; 2024 Feb; 48(2):102283. PubMed ID: 38219821
[TBL] [Abstract][Full Text] [Related]
6. Competing risk nomogram for predicting cancer-specific mortality in patients with non-melanoma skin cancer.
Tang L; Zhang L; Zeng Y; Li Y
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8817-8827. PubMed ID: 37142808
[TBL] [Abstract][Full Text] [Related]
7. Clinical features of sarcomatoid change in patients with intrahepatic cholangiocarcinoma and prognosis after surgical liver resection: A Propensity Score Matching analysis.
Wang T; Kong J; Yang X; Shen S; Zhang M; Wang W
J Surg Oncol; 2020 Mar; 121(3):524-537. PubMed ID: 31867746
[TBL] [Abstract][Full Text] [Related]
8. A Myeloid Signature-Based Nomogram Predicts the Postoperative Recurrence of Intrahepatic Cholangiocarcinoma.
Liang J; Zhou H; Huang XQ; Liu YF; Zhang L; He D; Cui Y; Guo J; Hu K; Wu C
Front Mol Biosci; 2021; 8():742953. PubMed ID: 34722632
[TBL] [Abstract][Full Text] [Related]
9. Nomogram predicting cancer-specific survival in elderly patients with stages I-III colon cancer.
Zheng P; Lai C; Yang W; Guo J; Xiao S; Chen Z
Scand J Gastroenterol; 2020 Feb; 55(2):202-208. PubMed ID: 32008420
[No Abstract] [Full Text] [Related]
10. Establishment of a Competing Risk Nomogram in Patients with Pulmonary Sarcomatoid Carcinoma.
Liang Z; Zhang E; Duan L; Weygant N; An G; Hu B; Yao J
Technol Cancer Res Treat; 2022; 21():15330338211068960. PubMed ID: 35179409
[No Abstract] [Full Text] [Related]
11. Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma.
Zhang R; Li Q; Fu J; Jin Z; Su J; Zhang J; Chen C; Geng Z; Zhang D
BMC Cancer; 2021 Feb; 21(1):112. PubMed ID: 33535978
[TBL] [Abstract][Full Text] [Related]
12. A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience.
Hyder O; Marques H; Pulitano C; Marsh JW; Alexandrescu S; Bauer TW; Gamblin TC; Sotiropoulos GC; Paul A; Barroso E; Clary BM; Aldrighetti L; Ferrone CR; Zhu AX; Popescu I; Gigot JF; Mentha G; Feng S; Pawlik TM
JAMA Surg; 2014 May; 149(5):432-8. PubMed ID: 24599477
[TBL] [Abstract][Full Text] [Related]
13. A competing-risk nomogram to predict cause-specific death in elderly patients with colorectal cancer after surgery (especially for colon cancer).
Wang Z; Wang Y; Yang Y; Luo Y; Liu J; Xu Y; Liu X
World J Surg Oncol; 2020 Feb; 18(1):30. PubMed ID: 32019568
[TBL] [Abstract][Full Text] [Related]
14. Developing a competing risk nomogram that predicts the survival of patients with a primary hepatic neuroendocrine tumor.
Lin J; Li X; Ding X; Chen Z; Wu Y; Zhao K
Front Med (Lausanne); 2022; 9():960235. PubMed ID: 36425110
[TBL] [Abstract][Full Text] [Related]
15. Predicting cancer-specific mortality in patients with parotid gland carcinoma by competing risk nomogram.
Luo X; Liu S; Chen Y; Qiu X; Huang D; Zhang D; Liang Q; Yang Y; Zeng X
Head Neck; 2021 Dec; 43(12):3888-3898. PubMed ID: 34632674
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of sarcopenia combined with preoperative fibrinogen-albumin ratio in patients with intrahepatic cholangiocarcinoma after surgery: A multicenter, prospective study.
Yu H; Wang M; Wang Y; Yang J; Deng L; Bao W; He B; Lin Z; Chen Z; Chen K; Zhang B; Liu F; Yu Z; Ye L; Jin B; Chen G
Cancer Med; 2021 Jul; 10(14):4768-4780. PubMed ID: 34105304
[TBL] [Abstract][Full Text] [Related]
17. Establishment and validation of a nomogram for predicting overall survival of node-negative perihilar cholangiocarcinoma.
Huang XT; Cai JP; Chen W; Huang CS; Li JH; Gan TT; Liang LJ; Yin XY
Asian J Surg; 2022 Feb; 45(2):712-717. PubMed ID: 34384677
[TBL] [Abstract][Full Text] [Related]
18. A multidimensional nomogram combining imaging features and clinical factors to predict the invasiveness and metastasis of combined hepatocellular cholangiocarcinoma.
Wang Y; Zhou CW; Zhu GQ; Li N; Qian XL; Chong HH; Yang C; Zeng MS
Ann Transl Med; 2021 Oct; 9(20):1518. PubMed ID: 34790724
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.
Yang Y; Sun S; Wang Y; Xiong F; Xiao Y; Huang J
Bosn J Basic Med Sci; 2021 Oct; 21(5):632-641. PubMed ID: 33577444
[TBL] [Abstract][Full Text] [Related]
20. Modified staging system of positive lymph nodes based nomogram in intrahepatic cholangiocarcinoma.
Zhao C; Li X; Luo L; Chen C; He C
Cancer Cell Int; 2023 Jul; 23(1):148. PubMed ID: 37516863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
